New valve implant aims to fix leaky heart valve without open surgery

NCT ID NCT05486832

Recruiting now Disease control Sponsor: Cardiovalve Ltd. Source: ClinicalTrials.gov ↗

First seen Jan 11, 2026 · Last updated Apr 28, 2026 · Updated 16 times

Summary

This study tests a new device called the Cardiovalve TR system to replace a leaky tricuspid valve in the heart. About 100 people with moderate to severe leakage and symptoms like shortness of breath will get the implant. The goal is to see if the device is safe and can reduce the leak, helping patients feel better and walk farther.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Charité university
RECRUITING

Berlin, 10117, Germany

Contact
Herzzentrum Uniklinik
RECRUITING

Cologne, 50937, Germany

Contact
Uniklinik Bonn
RECRUITING

Bonn, 53127, Germany

Contact
University Heart Center Lübeck
RECRUITING

Lübeck, 20251, Germany

Contact
Universitäres Herz
RECRUITING

Hamburg, 20251, Germany

Contact
Universität Bochum
RECRUITING

Bad Oeynhausen, 32545, Germany

Contact
Universitätsklinikum - Regensburg
RECRUITING

Regensburg, 93053, Germany

Contact

Conditions

Explore the condition pages connected to this study.

TRICUSPID REGURGITATION